Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators

Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators

US Patent 10780092 · Granted Sep 22, 2020

Estimated economic value: $1,234,723,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy2025
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2024
Carbamate and urea compounds as multikinase inhibitors2022
Purine inhibitors of human phosphatidylinositol 3-kinase delta2021
Cyclic compounds as immunomodulating agents2021
Macrocyclic compounds as TRK kinase inhibitors and uses thereof2021
Insulin dimer-incretin conjugates2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021